Pascal Soriot, AstraZeneca’s chief executive, made waves at this year’s Boao Forum in China by boldly declaring the nation’s position as a key innovator in the pharmaceutical industry. His stance,
Pharmaceutical7- Page
192Articles
AstraZeneca, Britain’s largest drugmaker, has faced sharp criticism over its handling of the detention of Leon Wang, its former head of international and China operations. Wang has reportedly remained in
Britain is poised to miss out on billions in pharmaceutical R&D investment and access to new medicines unless urgent reforms are made to the NHS medicine rebate system, according to
Drugmaker Regeneron Pharmaceuticals has announced plans to acquire 23andMe Holding for $256 million through a bankruptcy auction. The purchase, set to conclude in the third quarter of the year, comes
GSK, one of the UK’s leading pharmaceutical companies, has committed up to $2 billion to acquire a promising new liver disease drug from Boston Pharmaceuticals. The latest acquisition aims to
President Donald Trump has issued an executive order aimed at tackling high drug prices in the United States, sparking concern and volatility across the global pharmaceutical industry. The announcement marks
Denmark’s Novo Nordisk has adjusted its annual revenue and profit forecasts downward following weaker-than-expected sales of its weight-loss drug Wegovy in the United States. The company, which became Europe’s most
AstraZeneca, the FTSE 100 pharmaceutical giant, has reaffirmed its full-year forecasts despite posting mixed first-quarter results and grappling with potential headwinds in major markets. The company reported a 10 per
British ministers are actively engaging with pharmaceutical companies regarding potential US tariffs, prompting calls for an emergency taskforce to safeguard medicine supplies. The UK government is working diligently to maintain
The American pharmaceutical giant Pfizer has discontinued the development of its experimental weight-loss pill following safety concerns, marking a significant setback in its pursuit of the lucrative anti-obesity market, estimated
Research suggests that thousands of lives could be saved and subsequent heart attacks or strokes prevented through the administration of two cost-effective medicines. The study, conducted jointly by Imperial College
A groundbreaking development in pharmaceutical research has unveiled gepotidacin as the first new antibiotic treatment for gonorrhoea in three decades, presenting significant market implications for healthcare investors. The innovation addresses
British pharmaceutical giant AstraZeneca has secured NHS approval for its groundbreaking breast cancer drug capivasertib, marking a significant milestone in oncology treatment. The twice-daily tablet, developed in Cambridge, demonstrates remarkable
Revolutionary NHS Cancer Vaccine Trial Signals Fresh Hope for Investment in UK Healthcare Innovation
The National Health Service has unveiled a groundbreaking initiative, offering accelerated access to a pioneering cancer vaccine trial. This strategic move demonstrates the UK’s commitment to maintaining its position at
UK Government Accelerates Clinical Trials and Improves Access to NHS Data The United Kingdom government has unveiled ambitious plans aimed at enhancing the speed of clinical trials and facilitating greater
Keir Starmer has announced a series of significant measures aimed at bolstering the car and pharmaceutical sectors as the UK grapples with a shifting global landscape following Donald Trump’s imposition
